ENDLOS-TURBO PUT - AMGEN | Market Closed - Bid/Ask 03:35:28 2024-05-28 pm EDT | Pre-market 02:19:16 am | |||
| 12.36 EUR | +7.29% |
|
12.53 | +1.38% |
| Current month | -17.82% | ||
| 1 month | -19.53% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-28 | 12.36 | +7.29% |
| 24-05-27 | 11.52 | -2.12% |
| 24-05-24 | 11.77 | +0.34% |
| 24-05-23 | 11.73 | +4.17% |
| 24-05-22 | 11.26 | +3.21% |
Real-time Boerse Frankfurt Warrants
Last update May 28, 2024 at 03:35 pm EDT
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ8BSQ |
| ISIN | DE000DJ8BSQ4 |
| Date issued | 2024-01-10 |
| Strike | 432.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 11.35 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 16.32 € |
|---|---|
| Lowest since issue | 10.08 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
300.2
USD
Average target price
316.3
USD
Spread / Average Target
+5.36%
- Stock Market
- Certificates
- Certificat
